Viewing Study NCT04672798



Ignite Creation Date: 2024-05-06 @ 3:33 PM
Last Modification Date: 2024-10-26 @ 1:52 PM
Study NCT ID: NCT04672798
Status: COMPLETED
Last Update Posted: 2023-06-05
First Post: 2020-12-11

Brief Title: BRITEPath- Phase 2
Sponsor: University of Pittsburgh
Organization: University of Pittsburgh

Study Overview

Official Title: The Center for Enhancing Treatment Utilization for Depression and Emergent Suicidality Phase 2-Study 3-BRITEPath
Status: COMPLETED
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: BRITEPath BP aims to support co-located mental health clinicians in the development of a high quality effective and personalized safety plan for referred patients who screen positive for depression andor suicidal ideation

BRITEPath utilizes BRITE a safety planning and emotion regulation app that is loaded on the patients smart phone and has previously been shown to be well accepted and to reduce suicide attempts compared to usual care in psychiatric inpatients HR 049 To support mental health clinicians in the development of effective safety plans study investigators will develop Guide2Brite G2B which provides step-by-step instructions for the mental health clinician on how to populate BRITE onto the patients smartphone and BRITEBoard a clinician dashboard that tracks patient symptoms app use and rating on helpfulness of different interventions assessed through BRITE
Detailed Description: BRITEPath has 3 components 1 BRITE an emotion regulation and safety planning phone app that is delivered by a co-located mental health MH clinician to adolescents at the time of their first therapy appointment 2 Guide2Brite which will guide the co-located MH clinician in working with the adolescent to population content onto BRITE and 3 BRITEBoard which is a clinician dashboard delivered to the MH clinician and PCP

Assignment of Interventions This study will utilize a 11 randomization scheme to randomize participants to receive BRITEPath intervention or Treatment as Usual TAU

Hypothesis The use of BRITEPath will decrease depressive symptoms distress and suicidality any self-injurious ideation urges or behavior as well as improve overall functioning compared to TAU

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
P50MH115838-02 NIH None httpsreporternihgovquickSearchP50MH115838-02